Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.

Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders

Open access
Huang, Yige, Liu, Bangyan, Sinha, Subhash C., Amin, Sadaf, Gan, Li · 2023 · Molecular Neurodegeneration

Abstract

DNA sensing is a pivotal component of the innate immune system that is responsible for detecting mislocalized DNA and triggering downstream inflammatory pathways. Among the DNA sensors, cyclic GMP-AMP synthase (cGAS) is a primary player in detecting cytosolic DNA, including foreign DNA from pathogens and self-DNA released during cellular damage, culminating in a type I interferon (IFN-I) response through stimulator of interferon genes (STING) activation. IFN-I cytokines are essential in mediating neuroinflammation, which is widely observed in CNS injury, neurodegeneration, and aging, suggesting an upstream role for the cGAS DNA sensing pathway. In this review, we summarize the latest developments on the cGAS-STING DNA-driven immune response in various neurological diseases and conditions. Our review covers the current understanding of the molecular mechanisms of cGAS activation and highlights cGAS-STING signaling in various cell types of central and peripheral nervous systems, such as resident brain immune cells, neurons, and glial cells. We then discuss the role of cGAS-STING signaling in different neurodegenerative conditions, including tauopathies, Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis, as well as aging and senescence. Finally, we lay out the current advancements in research and development of cGAS inhibitors and assess the prospects of targeting cGAS and STING as therapeutic strategies for a wide spectrum of neurological diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13024-023-00672-x

Cites

136 of 136 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Activation of the cGAS-STING pathway by cytosolic DNA. Foreign (bacterial, viral) or self (mitochondrial, genomic) DNA in the cytosol can be sensed by cGAS, which produces cGAMP from ATP and GTP. cGAMP binds to and phosphorylates STING, inducing STING activation. STING further translocates from the ER to the Golgi apparatus. Phosphorylated STING recruits TBK1 and the IKK kinase, triggering innate immune response, including transcription of IFN-I and other immunomodulatory genes via phosphorylating IRF3 or activating NF-κB, respectively
Fig. 1 Activation of the cGAS-STING pathway by cytosolic DNA. Foreign (bacterial, viral) or self (mitochondrial, genomic) DNA in the cytosol can be sensed by cGAS, which produces cGAMP from ATP and GTP. cGAMP binds to and phosphorylates STING, inducing STING activation. STING further translocates from the ER to the Golgi apparatus. Phosphorylated STING recruits TBK1 and the IKK kinase, triggering innate immune response, including transcription of IFN-I and other immunomodulatory genes via phosphorylating IRF3 or activating NF-κB, respectivelyCC BY · PubMed Central
Fig. 2 cGAS activation in different CNS diseases and conditions. Activation of cGAS-STING-IFN-I signaling is a convergent pathway in various CNS diseases and conditions. In AD, the accumulation of tau tangles and amyloid plaques can lead to the activation of cGAS [46–48]. In PD, PINK1 and PRKN mutations and αSyn preformed fibril (αSyn-PFF) can induce cGAS activation [24, 49]. In ALS, Mutant TDP-43 protein can activate cGAS [29]. C9orf72 mutation leads to impaired degradation of STING, causing activation of the IFN-I response [50]. In Huntington’s disease (HD), cGAS activation is induced by DNA damage caused by mutant HTT protein (mHTT) [51]. In traumatic brain injury (TBI), traumatic impact induces DNA damage and neuronal death, activating cGAS by DNA released from dying neurons [52, 53]. In the context of aging and senescence, the activation of cGAS-STING is an important contributor to the development of senescence and senescence-associated secretory phenotype (SASP) [18, 54–57]
Fig. 2 cGAS activation in different CNS diseases and conditions. Activation of cGAS-STING-IFN-I signaling is a convergent pathway in various CNS diseases and conditions. In AD, the accumulation of tau tangles and amyloid plaques can lead to the activation of cGAS [46–48]. In PD, PINK1 and PRKN mutations and αSyn preformed fibril (αSyn-PFF) can induce cGAS activation [24, 49]. In ALS, Mutant TDP-43 protein can activate cGAS [29]. C9orf72 mutation leads to impaired degradation of STING, causing activation of the IFN-I response [50]. In Huntington’s disease (HD), cGAS activation is induced by DNA damage caused by mutant HTT protein (mHTT) [51]. In traumatic brain injury (TBI), traumatic impact induces DNA damage and neuronal death, activating cGAS by DNA released from dying neurons [52, 53]. In the context of aging and senescence, the activation of cGAS-STING is an important contributor to the development of senescence and senescence-associated secretory phenotype (SASP) [18, 54–57]CC BY · PubMed Central
Fig. 3 Targeting cGAS preserves MEF2C-mediated cognitive resilience against tauopathy. In disease or vulnerable conditions, pathogenic tau activates the cGAS-dependent IFN response via mtDNA leakage in microglia and a reduction of the MEF2C transcriptional network in excitatory and inhibitory neurons, resulting in cognitive dysfunction. Loss of cGAS through genetic deletion or pharmacological inhibition reduces the IFN response in microglia and enhances the MEF2C transcriptional network in neurons, resulting in cognitive resilience
Fig. 3 Targeting cGAS preserves MEF2C-mediated cognitive resilience against tauopathy. In disease or vulnerable conditions, pathogenic tau activates the cGAS-dependent IFN response via mtDNA leakage in microglia and a reduction of the MEF2C transcriptional network in excitatory and inhibitory neurons, resulting in cognitive dysfunction. Loss of cGAS through genetic deletion or pharmacological inhibition reduces the IFN response in microglia and enhances the MEF2C transcriptional network in neurons, resulting in cognitive resilienceCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 135 references

Cited by

See all 179

Metadata

Authors
Huang, Y., Liu, B., Sinha, S. C., Amin, S., & Gan, L.
Affiliations
Weill Cornell Medicine (US)
Corresponding author
Gan, Li
Venue
Molecular Neurodegeneration
Published
2023-11-08
Volume
18
Issue
1
Pages
79-79
ISSN
1750-1326 (ISSN-L)
OpenAlex
W4388483815
Cited by
164
References
135
Citations by year
2026: 60 · 2025: 70 · 2024: 34
FWCI
4.56
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Neurodegeneration (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institute on Aging (R01AG072758, R01AG054214, R01AG074541)
  • Tau Consortium
  • JPB Foundation
  • Cure Alzheimer's Fund
  • BrightFocus Foundation (A20201312F)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Keywords
cGAS-STING pathway, DNA sensing, cytosolic DNA, type I interferon, neuroinflammation, neurodegenerative diseases, tauopathy, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, aging, cellular senescence, cGAS inhibitors, therapeutic targeting, glial cells, neurons, innate immunity
MeSH terms
DNA, Humans, Interferon Type I, Nervous System Diseases, Nucleotidyltransferases, Signal Transduction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders. https://app.cochat.ai/papers/10.1186/s13024-023-00672-x
The paper
Huang, Y., Liu, B., Sinha, S. C., Amin, S., & Gan, L. (2023). Mechanism and therapeutic potential of targeting cGAS-STING signaling in neurological disorders. Molecular Neurodegeneration. https://doi.org/10.1186/s13024-023-00672-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.